New research sheds light on the biomolecular dangers of night shift work.

Vigorous exercise burns fat more in males than in females, but the benefits of exercise are broad for both sexes.

Scientists have learned more about how to protect the insulin-producing cells that die in patients with Type 1 diabetes.

PNNL researchers helped identify a fragment from the SARS-CoV-2 virus that spurs severe illness.

Scientists have learned more about how drug resistance develops in patients with acute myeloid leukemia and how the process might be slowed.

An energy expert and economist who has played a leading role in formulating and coordinating U.S. climate policy is the new director of the Joint Global Change Research Institute in College Park, Maryland.

PNNL is collaborating with Microsoft, Micron and other partners to make computational chemistry broadly available.

Scientists have opened a new view into the workings of the central nervous system, finding a diverse set of important molecules.

Scientists have taken an important step forward in predicting who will develop Type 1 diabetes months before symptoms appear.

A new method to convert waste plastic to fuel and raw materials promises to help close the carbon cycle at mild temperature and with high yield.

A detailed snapshot of proteins by PNNL scientists marks a big step toward a diagnostic blood test for a deadly form of liver disease.

PNNL scientists carve a path to profit from carbon capture by creating a system that efficiently captures CO2 and converts it into one of the world’s most widely used chemicals: methanol.

Scientists can detect the virus that causes COVID-19 by using a bubble that spills its contents like a piñata when encountering the virus.

The Washington State Academy of Sciences added six people from PNNL to its 2022 class of inductees.

Soil and its microbial inhabitants from Washington state are heading for the International Space Station today.

The virus that causes COVID-19 takes over the body’s fat-processing system and boosts cellular triglycerides as it causes disease.

PNNL will demonstrate how new technologies, innovative approaches and partnering with others can lead to net-zero emissions and decarbonization of operations.

A study raises questions about how far droplets, like those that carry the virus that causes COVID-19, can travel before becoming harmless.

PNNL scientists are protecting first responders and others by expanding what’s known about fentanyl, the driver of the opioid epidemic.

PNNL wins three FLC awards in annual technology innovation competition.